Amylyx Pharmaceuticals (AMLX) Gross Margin (2022 - 2024)
Amylyx Pharmaceuticals (AMLX) posted quarterly Gross Margin of 100.0% for Q4 2024, up 863.0% year-over-year from 10.38% in Q1 2024, and little changed quarter-over-quarter from 100.0% in Q3 2024.
Amylyx Pharmaceuticals (AMLX) Gross Margin (2022 - 2024) Analysis & Trends
Amylyx Pharmaceuticals' Gross Margin history runs 3 years deep, the most recent figure standing at 100.0% for Q4 2024.
- In Q4 2024, Gross Margin rose 863.0% year-over-year to 100.0%; the TTM figure through Sep 2025 stood at 100.0% (up 771.0% YoY), while the FY2024 annual figure was 93.19%, down 13.0% from the prior year.
- Gross Margin for Q4 2024 stood at 100.0%, roughly flat from 100.0% in the prior quarter.
- The five-year high for Gross Margin was 100.0% in Q3 2024, with the low at 50.14% in Q3 2022.
- The 3-year median for Gross Margin is 93.81% (2023), against an average of 90.3%.
- The sharpest annual moves came in 2023 and 2024: Gross Margin surged 4477 bps in 2023, then soared 69 bps in 2024.
- Amylyx Pharmaceuticals' Gross Margin stood at 87.11% in 2022, then gained by 5 bps to 91.37% in 2023, then advanced by 9 bps to 100.0% in 2024.
- Business Quant data shows AMLX's Gross Margin at 100.0% in Q4 2024, 100.0% in Q3 2024, and 99.22% in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.71 Bn | 42.75 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.11 Bn | 39.45 Bn | 2.15 Bn | 51.98% |
| 3 | Zoetis | 31.62 Bn | 29.94 Bn | 1.05 Bn | 42.63% |
| 4 | Takeda Pharmaceutical | 28.72 Bn | 22.92 Bn | 5.10 Bn | 66.66% |
| 5 | United Therapeutics | 22.33 Bn | 19.67 Bn | 683.80 Mn | 87.30% |
| 6 | Viatris | 18.83 Bn | 17.95 Bn | 1.46 Bn | 38.77% |
| 7 | Neurocrine Biosciences | 15.62 Bn | 15.23 Bn | 935.80 Mn | 97.58% |
| 8 | Elanco Animal Health | 12.10 Bn | 11.57 Bn | 798.00 Mn | 58.33% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Amylyx Pharmaceuticals | 4.28 Bn | 4.28 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 100.00% |
| Sep 30, 2024 | 100.00% |
| Jun 30, 2024 | 99.22% |
| Mar 31, 2024 | 93.29% |
| Dec 31, 2023 | 91.37% |
| Sep 30, 2023 | 94.92% |
| Jun 30, 2023 | 94.32% |
| Mar 31, 2023 | 92.60% |
| Dec 31, 2022 | 87.11% |
| Sep 30, 2022 | 50.14% |